tislelizumab
beigene,novartis
['tislelizumab', 'truce02', 'bladder', 'urothelial']
#truce02: an open label, single-arm, phase ii study of tislelizumab combined with nab-paclitaxel for high-risk non-muscle-invasive urothelial bladder carcinoma. presented by zesheng an, md. #asco22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology